Fig. 6From: circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinomacircPSD3 interacts with HDAC1 to inhibit its nuclear translocation. (A) Schematic of the TRAP assay. (B) Relative expression levels of circPSD3 and GST in HCC-LM9 cells co-transfected with the circPSD3-MS2 and GST-MS2 vectors. (C) Venn diagram of circPSD3-interacting proteins, as identified by TRAP assay and LC-MS/MS. (D) HDAC1-specific peptide sequence identified using LC-MS/MS. (E) TRAP assay and western blotting analysis of the interaction between circPSD3 and HDAC1. (F) RIP assay of the enrichment of anti-HDAC1 on circPSD3 in HCC cells. (G) FISH and immunofluorescence analysis of the co-localisation of circPSD3 and HDAC1 in the cytoplasm of HCC cells. Scale bar = 20 μm; Scale bar (zoom) = 10 μm. (H) Relative expression levels of circPSD3 in HCC cells transfected with HDAC1 siRNA. (I) Schematic of the circPSD3 binding site on HDAC1 and FLAG-tagged HDAC1 truncated mutants. (J) Western blotting analysis of the protein expression of the negative control, wild-type, and truncated HDAC1 mutants in lysates of HEK-293T cells transfected with the indicated vectors. (K) RIP analysis of the enrichment of the negative control, wild-type, and truncated HDAC1 mutants on circPSD3 in HEK-293T cells. (L) HDAC1 nuclear localisation signal predicted using DeepLoc-1.0 software (upper) and circPSD3 binding site on HDAC1 (lower). (M) Immunofluorescence analysis of the subcellular localisation of HDAC1 in circPSD3 knockdown and control HCC cells. Scale bar = 20 μm. (N) Western blotting analysis of HDAC1 expression in the nuclear (N) and cytoplasmic (C) fractions of circPSD3 knockdown and control HCC cells. Data are shown as the mean ± SD. Statistical analyses were performed using unpaired Student’s t-tests (NS, no statistical significance; **p < 0.01; ***p < 0.001). circPSD3, circRNA pleckstrin and Sect. 7 domain containing 3; FISH, fluorescence in situ hybridisation; HCC, hepatocellular carcinoma; HDAC1, histone deacetylase 1; LC-MS/MS, liquid chromatography–tandem mass spectrometry; RIP, RNA immunoprecipitation; TRAP, MS2-tagged RNA affinity purification; siRNA, small interfering RNABack to article page